U.S. lawmakers acknowledged Thursday that the ambitious target of 1 million new coronavirus tests, which were scheduled to be completed within the week, will not be met, and confirmed that only a portion of the COVID-19 test will be ready by Friday, according tomedia outlet SlashGear. The Trump administration has previously promised to increase the CDC’s limited number of official new coronavirus testing agents in response to public health needs to significantly improve testing capabilities.
Efforts to increase COVID-19 testing in the United States have encountered many obstacles in recent weeks. The U.S. Centers for Disease Control and Prevention (CDC) has developed a testing reagent that is being distributed in a small number of locations in different states across the United States. However, reports emerged quickly thereafter that the testwas were not working properly. The CDC blames one of these reagents and begins to redevelop them. Even so, it can provide far fewer tests than healthcare companies require. The CDC recommended earlier this week that it could test up to 75,000 people in public health labs using its own testing reagents.
The CDC and other agencies are counting on third-party testing, which the U.S. Food and Drug Administration (FDA) says will soon be available in large numbers. In fact, the FDA and White House officials have previously promised that the U.S. will have the capacity to conduct 1 million new coronavirus tests by the end of the week. But now, the United States senator has made it clear that this is simply not possible.
“No one million people will be tested by the end of the week,” Bloomberg reported. It will actually be much less than that number. To date, this has been done through the public health sector. “
Instead, the U.S. government is in the process of “releasing” new coronavirus testing reagents. After that, training on how to actually conduct the testing process is needed, which mPs believe could take days or weeks. “It’s going to take some time to get, receive, re-examine them, and put them into use,” explains Senator James Lankford, Republican of Oklahoma. “
The briefing was chaired by representatives of the Department of Homeland Security, the National Institute of Allergy and Infectious Diseases, and the Centers for Medicare and Medicaid. According to the senators present, a document with new coronavirus information and good practices to avoid infection was distributed. However, there is no guidance on the actual detection of the disease.
The long incubation period of COVID-19 is a big problem
The long incubation period of the new coronavirus has exacerbated the increasing number of new coronavirus diagnoses in the United States, leading to detection bottlenecks. This may last for 1-2 weeks, during which time the individual may not experience any symptoms. Even if there are symptoms, symptoms appear to be flu-like coughs, breathing difficulties and fevers, which also means they can easily be confused about other things.
In conjunction with guidance from the CDC, WHO, and other agencies, people who suspect they have symptoms or who have been in contact with a potential infection (e.g., to areas where a newly diagnosed coronavirus has been diagnosed) contact a health care provider for testing, resulting in a discrepancy between the number of people who want to test and the ability to actually test. Complicating the problem, the 14-day police isolation recommendation has proved difficult to implement. At least one person who was later diagnosed with COVID-19 has been identified in the United States who did not follow the isolation protocol.